Bullous pemphigoid in an elderly woman: clinical recognition and management in internal medicine
Bullous pemphigoid in an elderly woman: clinical recognition and management in internal medicine
DOI:
https://doi.org/10.51473/rcmos.v1i1.2026.2045Keywords:
Bullous pemphigoid; Autoimmune blistering disease; Hemidesmosomal proteins; Pruritus.Abstract
Bullous pemphigoid is a chronic autoimmune subepidermal blistering disease mediated by circulating autoantibodies targeting hemidesmosomal proteins within the basement membrane zone. It predominantly affects elderly individuals and is clinically characterized by intense pruritus, tense blister formation, cutaneous fragility, and an elevated risk of secondary infection. Early manifestations are frequently nonspecific, often presenting as generalized pruritus or eczematous lesions, which may contribute to delayed diagnosis and management. In susceptible individuals, drug exposure has been identified as a potential triggering factor. Due to the risk of systemic complications and the often atypical initial presentation, internal medicine physicians commonly serve as the first point of contact, particularly in hospital settings, underscoring the importance of early recognition and appropriate referral for definitive diagnosis and treatment.
Downloads
References
Schmidt, E.; Zillikens, D. Bullous pemphigoid. The Lancet, 2013.
Amber, K. T.; Murrell, D. F. Autoimmune blistering diseases of the skin. Journal of Allergy and Clinical Immunology, 2016.
Bullous Pemphigoid in an Elderly Woman.
Relatório técnico publicado no repositório científico internacional Zenodo, 2026.
Downloads
Published
Issue
Section
Categories
License
Copyright (c) 2026 Bibiana Ramos Goulart , Arthur Ineu Figueiredo, Cristiane Koplin (Autor)
This work is licensed under a Creative Commons Attribution 4.0 International License.
This work is licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This means you are free to:
- Share — copy and redistribute the material in any medium or format.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
The use of this material is conditioned upon proper attribution to the original author(s), providing a link to the license, and indicating if changes were made. The license does not require permission from the author or the publisher as long as these conditions are met.
The Creative Commons license logo is displayed permanently in the footer of the journal.
The copyright of the manuscript can be retained by the authors without restrictions and can be requested at any time, even after publication in the journal.
How to Cite
